Cabanex 0.5 mg (Cabergoline 0.5 mg)

Cabanex 0.5 mg contains Cabergoline, a dopamine receptor agonist primarily used to treat hyperprolactinemia, a condition caused by elevated levels of prolactin hormone. High prolactin can lead to irregular menstrual cycles, infertility, and unexpected breast milk production in women, while in men it may result in decreased libido and erectile dysfunction.

Cabergoline works by mimicking the action of dopamine, a brain chemical that naturally inhibits prolactin release. By lowering prolactin levels, Cabanex helps restore hormonal balance, enhance fertility, and regulate menstrual functions. It is often prescribed as a once or twice-weekly oral dose, based on individual patient needs and hormone levels.

Common side effects include nausea, dizziness, constipation, or fatigue. Rare but serious risks involve heart valve complications, especially with long-term use, so regular follow-ups and cardiac monitoring may be advised for high-dose or prolonged therapy.

Cabanex 0.5 mg offers a targeted and effective treatment for prolactin-related disorders, making it a preferred option in endocrinology and reproductive medicine.